Featured Research

from universities, journals, and other organizations

Rare jaw tumor: Discovery could pave way to new treatment

Date:
May 27, 2014
Source:
Stanford University Medical Center
Summary:
The mutations underlying a rare, understudied type of jaw tumor called ameloblastoma have been discovered by researchers. the researchers identify mutations in two genes that are associated with 80 percent of ameloblastoma cases. The Food and Drug Administration has already approved drugs for other cancers caused by these mutations. Now, the paper's authors are pursuing funding for a pilot study to use one of these drugs to treat ameloblastoma.

(From left) Researchers Robert West, Andrew McClary, Robert Sweeney and Jonathan Pollack and their colleagues found two genes that are linked with a majority of cases of a rare type of jaw tumor.
Credit: Image courtesy of Stanford University Medical Center

Researchers at the Stanford University School of Medicine have identified the mutations underlying a rare, understudied type of jaw tumor called ameloblastoma.

Related Articles


In a paper published online May 25 in Nature Genetics, the researchers identify mutations in two genes that are associated with 80 percent of ameloblastoma cases. The Food and Drug Administration has already approved drugs for other cancers caused by these mutations. Now, the paper's authors are pursuing funding for a pilot study to use one of these drugs to treat ameloblastoma.

Doctors diagnose about 300 to 600 cases of ameloblastoma in the United States each year. Neither drugs nor radiation have been successful at eradicating the cancer, leaving surgery as the only option. Though the tumors are considered benign, surgeons must cut away large margins around the growths to try to ensure that it will not reoccur. Because the operation removes a portion of the jaw as well as arteries and facial nerves, the patients require extensive reconstructive surgeries and rehabilitation to regain the ability to smile and chew.

"They require quite a disfiguring surgery to treat," said Andrew McClary, MD, chief pathology resident at Stanford Hospital & Clinics. Patients often lose a large section of their jaw, he said. McClary shares lead authorship of the paper with postdoctoral scholars Robert Sweeney, MD, and Benjamin Myers, PhD, and with research assistant Jewison Biscocho.

The quest to find underlying mutations

McClary first became interested in this rare disease when he examined a slide from a patient's tumor. He often uses a mnemonic trick to remember a disease by associating its name with the gene mutations that cause it. But he found that ameloblastomas had no known gene abnormalities.

To find the underlying mutations causing these tumors, McClary worked with colleagues at the University of British Columbia in Vancouver, the Cleveland Clinic in Ohio and the Oregon Health Sciences University in Portland to collect tumor samples. Because the disease is so rare, they only had older bits of tissue that had been preserved for microscopy work, not genetic studies.

Fortunately, the researchers still were able to sequence the mRNA -- copies of genes that tell the cell how to make specific proteins -- even when the mRNA was old and degraded. The researchers then embarked on what McClary called a "fishing expedition" to find the mRNAs with the mutations that caused the tumors.

By sequencing all the mRNAs in two ameloblastoma samples, they identified two genes that carried mutations involved in growth and development, called SMO and BRAF. They then sequenced these genes in additional tissue samples to confirm their presence in other ameloblastomas. SMO mutations were most often found in the upper jaw, while BRAF mutations occurred predominantly in the lower jaw.

"These genes are essential for delivering signals of growth and development, particularly in developing organs," said Robert West, MD, PhD, associate professor of pathology at Stanford and a senior author of the study. "But it's increasingly apparent that they are often mutated in cancers."

Possible therapies

Perhaps most promising, researchers found that there are already FDA-approved drugs for cancers with mutations in the same developmental pathway. A drug called vemurafenib is toxic to ameloblastoma cell cultures that harbor a BRAF mutation, they found. This drug is effective against melanomas that carry the same mutant gene. Researchers also found that a compound called arsenic trioxide, an approved anti-leukemia drug, is effective at blocking the mutant SMO protein.

In April, West and McClary began collaborating with Dimitrios Colevas, MD, associate professor of oncology at Stanford, to plan a small pilot study to assess whether vemurafenib can shrink ameloblastoma tumors that have a BRAF mutation.

In future work, the researchers plan to conduct more fishing expeditions to look for these mutations in other types of tumors, cysts and lesions in the jaw.

"These are findings you can hang your hat on," said West. "It really opens up a number of different avenues of research where we can confidently go forward and make a lot of molecular inroads into a set of tumors and lesions in the mouth that previously we haven't known much about, or been able to do much but excise them."

The work also has implications for future studies of tooth development. If these specific genes cause unbridled growth when they accumulate mutations, then they likely play an important role in the formation of teeth in the embryo, the researchers say.

Reaching out to patients

Throughout this project, McClary has engaged with an ameloblastoma Facebook group to hear members' stories and to learn what a patient goes through during the initial surgery and subsequent facial reconstruction. He plans to conduct a webinar with the group, and can't wait to share his findings with them.

"It's a great motivator," he said about his involvement with the group. "Our face is a special place. I couldn't imagine not smiling."


Story Source:

The above story is based on materials provided by Stanford University Medical Center. The original article was written by Patricia Waldron. Note: Materials may be edited for content and length.


Journal Reference:

  1. Robert T Sweeney, Andrew C McClary, Benjamin R Myers, Jewison Biscocho, Lila Neahring, Kevin A Kwei, Kunbin Qu, Xue Gong, Tony Ng, Carol D Jones, Sushama Varma, Justin I Odegaard, Toshihiro Sugiyama, Souichi Koyota, Brian P Rubin, Megan L Troxell, Robert J Pelham, James L Zehnder, Philip A Beachy, Jonathan R Pollack, Robert B West. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nature Genetics, 2014; DOI: 10.1038/ng.2986

Cite This Page:

Stanford University Medical Center. "Rare jaw tumor: Discovery could pave way to new treatment." ScienceDaily. ScienceDaily, 27 May 2014. <www.sciencedaily.com/releases/2014/05/140527100648.htm>.
Stanford University Medical Center. (2014, May 27). Rare jaw tumor: Discovery could pave way to new treatment. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2014/05/140527100648.htm
Stanford University Medical Center. "Rare jaw tumor: Discovery could pave way to new treatment." ScienceDaily. www.sciencedaily.com/releases/2014/05/140527100648.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Christmas Kissing Good for Health

Christmas Kissing Good for Health

Reuters - Innovations Video Online (Dec. 22, 2014) Scientists in Amsterdam say couples transfer tens of millions of microbes when they kiss, encouraging healthy exposure to bacteria. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Brain-Dwelling Tapeworm Reveals Genetic Secrets

Brain-Dwelling Tapeworm Reveals Genetic Secrets

Reuters - Innovations Video Online (Dec. 22, 2014) Cambridge scientists have unravelled the genetic code of a rare tapeworm that lived inside a patient's brain for at least four year. Researchers hope it will present new opportunities to diagnose and treat this invasive parasite. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins